Cargando…
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
Monoclonal gammopathy of undetermined significance (MGUS) is rare in young patients (age <40 years at diagnosis), with a prevalence of <0.3%, representing ~2% of all patients with MGUS. We hypothesized that MGUS detected in young patients may be associated with a higher risk of progression. We...
Autores principales: | Pang, Li, Rajkumar, S. Vincent, Kapoor, Prashant, Buadi, Francis, Dispenzieri, Angela, Gertz, Morie, Lacy, Martha, Kyle, Robert, Kumar, Shaji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873268/ https://www.ncbi.nlm.nih.gov/pubmed/33563898 http://dx.doi.org/10.1038/s41408-021-00406-6 |
Ejemplares similares
-
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022) -
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022) -
Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019) -
A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Koo, Hyun, et al.
Publicado: (2011) -
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
por: Lomas, Oliver C., et al.
Publicado: (2020)